Join the Osteoarthritis group to help and get support from people like you.
Osteoarthritis News (Page 3)
Related terms: Arthritis, Osteoarthritis, Degenerative Arthritis, Degenerative joint disease (DJD), Hypertrophic Osteoarthritis, Osteoarthrosis, DJD, OA, Degenerative Joint disease, Joint Pain, Gonarthrosis, Sacroiliac Arthritis
Nonsurgical Treatment Works Well for Arthritic Thumbs
TUESDAY, Nov. 7, 2023 – Patients with osteoarthritis in their thumbs can get good long-term outcomes with orthotics and exercise therapy, and avoid surgery at the same time, new research shows. "Our...
Methotrexate Reduces Pain in Hand Osteoarthritis With Synovitis
MONDAY, Nov. 6, 2023 – For patients with hand osteoarthritis and synovitis, methotrexate has a potentially clinically meaningful effect on reducing pain, with no increase in adverse events,...
1 in 5 U.S. Adults Now Has Arthritis
TUESDAY, Oct. 17, 2023 – Arthritis is becoming a disease of the masses, striking 21% of U.S. adults, or over 53 million people, a new report shows. “It's important first to point out that arthritis i...
21.2 Percent of U.S. Adults Had Diagnosed Arthritis From 2019 to 2021
THURSDAY, Oct. 12, 2023 – An estimated 21.2 percent of U.S. adults had diagnosed arthritis from 2019 to 2021, with most cases among adults aged 45 years and older, according to research published in...
Arthritic Hands: What Works (and Doesn't) to Ease the Pain?
MONDAY, Oct. 2, 2023 – Millions of people who live with the pain and stiffness of arthritis in their hands get steroid or hyaluronic acid injections directly into their finger joints in the hopes of...
Oral NSAIDs, Glucocorticoids Seem Effective for Hand Osteoarthritis
FRIDAY, Sept. 29, 2023 – Oral nonsteroidal anti-inflammatory drugs (NASIDs) and glucocorticoids seem to be effective for hand osteoarthritis (OA), according to a review published online Sept. 28 in...
Using Meds to Manage Your Arthritis Pain: An Overview
TUESDAY, Sept. 19, 2023 – Millions of Americans suffer from arthritis, and many reach for medication to ease their joint pain and inflammation. The options might seem overwhelming, though. Here, the...
FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain
TEL AVIV, Israel, May 31, 2018 (GLOBE NEWSWIRE) – Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration...
FDA Medwatch Alert: Limbrel Capsules by Primus Pharmaceuticals: FDA Advisory - Linked to Potentially Life-Threatening Health Problems
ISSUE: The U.S. Food and Drug Administration is investigating serious adverse events involving Limbrel, a product in capsule form currently being marketed as a medical food to manage the metabolic...
Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis Knee Pain
BURLINGTON, Mass., Oct. 06, 2017 (GLOBE NEWSWIRE) – Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Food and Drug Administration (FDA) approved Zilretta (triamcinolone...
FDA Approves Vivlodex (meloxicam) for Osteoarthritis Pain
PHILADELPHIA, October 23, 2015 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the United States Food and ...
Iroko Pharmaceuticals Gains FDA Approval of Zorvolex for Management of Osteoarthritis Pain
PHILADELPHIA, August 25, 2014 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the United States Food and Drug A...
FDA Medwatch Alert: Super Arthgold by Nano Well-being Health: Recall - Undeclared Drug Ingredients
ISSUE: Nano Well-being Health Inc. issued a voluntary recall of Super Arthgold, 500 mg capsules to the consumer level. FDA laboratory analysis has found the product to contain chlorzoxazone,...
FDA Approves Monovisc, a New Single Injection Treatment for Pain Due to Osteoarthritis of the Knee
BEDFORD, Mass., Feb. 25, 2014 --(BUSINESS WIRE)-- Anika Therapeutics, Inc. today announced it has received marketing approval for Monovisc from the U.S. Food and Drug Administration (FDA). Monovisc...
FDA Medwatch Alert: Reumofan Plus Dietary Supplement Relabeled and Sold as “WOW”: Public Warning - Undeclared Drug Ingredients
ISSUE: The U.S. Food and Drug Administration (FDA) is warning the public that the potentially harmful dietary supplement product Reumofan Plus is being relabeled and sold under the name “WOW.” The pr...
Further information
Related drug support groups
prednisone, Cymbalta, ibuprofen, naproxen, meloxicam, aspirin, diclofenac, duloxetine, methylprednisolone, view more... Celebrex, Aleve, Advil, Voltaren, triamcinolone, betamethasone, Motrin, cortisone, Medrol, Excedrin, indomethacin, Mobic, Arthritis Pain, glucosamine, nabumetone